474700 Sigma-AldrichMevastatin - CAS 73573-88-3 - Calbiochem
An antibiotic that acts as a potent inhibitor of HMG-CoA reductase, thus suppressing Ras farnesylation.
More>> An antibiotic that acts as a potent inhibitor of HMG-CoA reductase, thus suppressing Ras farnesylation. Less<<Sinónimos: Compactin
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
73573-88-3 | C₂₃H₃₄O₅ |
Products
Número de referencia | Embalaje | Cant./Env. | |
---|---|---|---|
474700-50MG | Ampolla de plást. | 50 mg |
Product Information | |
---|---|
CAS number | 73573-88-3 |
ATP Competitive | N |
Form | White solid |
Hill Formula | C₂₃H₃₄O₅ |
Chemical formula | C₂₃H₃₄O₅ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | HMG-CoA reductase |
Purity | ≥95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | EK7907100 |
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
474700-50MG | 07790788050429 |
Documentation
Mevastatin - CAS 73573-88-3 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Mevastatin - CAS 73573-88-3 - Calbiochem Certificados de análisis
Cargo | Número de lote |
---|---|
474700 |
Referencias bibliográficas
Visión general referencias |
---|
Sugiyama, M., et al. 2000. Biochem. Biophys. Res. Commun. 271, 688. Hug, T., et al. 1995. Pflugers Archiv. Eur. J. Physiol. 429, 682. Belo, R.S., et al. 1993. Mol. Cell. Biochem. 126, 159. McLeish, K.R., et al. 1993. Biochem. Biophys. Res. Commun. 197, 763. Keyomarsi, K., et al. 1991. Cancer Res. 51, 3602. Jackson, J.H., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 3042. Kita, T., et al. 1980. J. Clin. Invest. 66, 1094. |